id: NEW:coronavirus_hospitalization_icu_admission_to_NEW:impaired_pulmonary_diffusion_capacity
name: Severe Coronavirus Infection (SARS/MERS) Requiring Hospitalization or ICU â†’
  Impaired Diffusing Capacity for Carbon Monoxide (DLCO)
from_node:
  node_id: NEW:coronavirus_hospitalization_icu_admission
  node_name: Severe Coronavirus Infection (SARS/MERS) Requiring Hospitalization or
    ICU
to_node:
  node_id: NEW:impaired_pulmonary_diffusion_capacity
  node_name: Impaired Diffusing Capacity for Carbon Monoxide (DLCO)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Severe SARS or MERS coronavirus infection triggers intense inflammatory
  response in lung tissue, particularly affecting the alveolar-capillary membrane'
- 'Step 2: Viral infection and host immune response cause diffuse alveolar damage,
  including destruction of type I and II pneumocytes and endothelial cells'
- 'Step 3: Acute phase damage leads to pulmonary fibrosis, interstitial thickening,
  and permanent structural changes to the alveolar-capillary interface'
- 'Step 4: Thickened or damaged alveolar-capillary membrane impairs gas diffusion,
  resulting in reduced DLCO that persists beyond acute infection'
- 'Step 5: Impaired diffusing capacity manifests as a common long-term pulmonary sequela
  in coronavirus survivors, detectable up to 6 months post-hospitalization'
evidence:
  quality_rating: A
  n_studies: 28
  primary_citation: 'H. Ahmed et al. 2020. Long-term clinical outcomes in survivors
    of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus
    outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
    Journal of Rehabilitation Medicine.'
  supporting_citations: []
description: 'Pooled meta-analysis of 28 studies examining SARS and MERS survivors
  found that impaired diffusing capacity for carbon monoxide (DLCO) is a common long-term
  complication, with a prevalence of 27% (95% CI: 15-45%) up to 6 months after hospitalization
  or ICU admission. This reflects persistent damage to the alveolar-capillary membrane
  from severe coronavirus infection.'
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.27
    type: prevalence
    ci_lower: 0.15
    ci_upper: 0.45
  p_value: null
  sample_size: null
moderators:
- name: time_since_infection
  direction: weakens
  strength: moderate
  description: Impaired DLCO prevalence measured up to 6 months post-admission; some
    recovery may occur over time but persistent deficits are common
- name: disease_severity
  direction: strengthens
  strength: moderate
  description: Study focused on hospitalized and ICU-admitted patients, representing
    more severe infections with likely greater pulmonary damage
